EPHB2 and synovial sarcoma: Similarly, these oncogenic effects are demonstrated in soft tissue sarcomas when EPHA3, EPHB2 and EPHB4 stimulate properties such as proliferation, increased motility, migration, invasion and metastasis of rhabdomyosarcoma and synovial sarcoma cells.